FDA Inspection
Labcorp Early Development Laboratories, Inc.Labcorp Early Development Laboratories, Inc. – FDA Inspection, Aug 30, 2023
Record Details
This FDA Inspection record concerns Labcorp Early Development Laboratories, Inc., with an inspection on August 30, 2023, issued by the Minneapolis District Office.
- Inspection Date
- August 30, 2023
View Company Profile
ID · fb698aa2-8acb-4c11-a164-90f3d5441e5d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1216326
- FDA center
- Biologics
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 58.190(a)Archives: data, documentation, specimens
- 21 CFR 58.33(a)Study director: follow study protocol
- 21 CFR 58.90(g)Animal care: analysis of feed and water
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Labcorp Early Development Laboratories, Inc.
8| Date | Classification | Office | Project area |
|---|---|---|---|
| May 7, 2025 | VAI | Minneapolis District Office | Human Cellular, Tissue, and Gene Therapies |
| February 14, 2020 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| September 5, 2019 | Not classified | Minneapolis District Office | |
| August 24, 2018 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| August 17, 2018 | VAI | Minneapolis District Office | Bioresearch Monitoring |
Other documents for Labcorp Early Development Laboratories, Inc.
- FDA Inspection 1269784 - 2025-05-07
- FDA Inspection 1121677 - 2020-02-14
- FDA Inspection 1106741 - 2019-09-05
- FDA Inspection 1065286 - 2018-08-24
- FDA Inspection 1064823 - 2018-08-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.